Abstract  Description  Claims  Drawing  Search report  Cited references 

WO2005000232A   [0003] 
CN101676267A   [0004] 
CN101675930A   [0004] 
WO2015085847A   [0005] 

Pembrolizumab in Patients with Advanced Triple Negative Breast Cancer: Phase Ib KEYNOTE-012 Study   [0005]